ATHENS, GA, United States of America

Marc Iuliucci

This inventor holds 1 USPTO granted patent. Top assignee: Purisys, Inc.. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Marc Iuliucci

Introduction

Marc Iuliucci is an accomplished inventor based in Athens, GA (US). He has made significant contributions to the field of cannabinoid research, particularly through his innovative work on D9-Tetrahydrocannabinol (D9-THC). His expertise and dedication to advancing this area of study have led to the development of valuable patents.

Latest Patents

Marc Iuliucci holds a patent for "Polymorphs of D9-THC naphthoylester." This patent relates to the preparation of D9-Tetrahydrocannabinol in high yields and high purity. The methods outlined in his patent provide a means of producing D9-Tetrahydrocannabinol efficiently, along with compositions that incorporate this compound.

Career Highlights

Throughout his career, Marc has demonstrated a commitment to innovation and excellence. His work at Purisys, Inc. has positioned him as a key player in the cannabinoid research sector. His contributions have not only advanced scientific understanding but have also paved the way for potential applications in various industries.

Collaborations

Marc has collaborated with talented individuals such as Gnel Mkrtchyan and Daniel M Hallow. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work.

Conclusion

Marc Iuliucci's contributions to the field of cannabinoid research through his patent on D9-THC naphthoylester exemplify his innovative spirit and dedication to advancing science. His work continues to influence the industry and inspire future research endeavors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…